Published 17:03 IST, November 24th 2020
Russia's 'Sputnik V' COVID-19 vaccine shows over 91.4% efficacy as per interim trial data
The world’s first COVID-19 vaccine to be registered, Russia’s Sputnik V, has announced its efficacy to be 91.4% based on the interim analysis of Phase 3 trials.
null | Image:
self
Advertisement
Loading...
17:03 IST, November 24th 2020